1. Moussavi S, Chatterji S, Verdes E, et al. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007;370:851–8.
2. Bromet E, Andrade LH, Hwang I, et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med. 2011;9:90.
3. Colombo G, Di Matteo S. Nel Trattamento della Depressione Maggiore Nelle Diverse Regioni Italiane: Il Ruolo di Venlafaxina [Budget impact analysis in the treatment of major depressive disorder on Italian Regions: The role of venlafaxine]. Milan: W.H.E.RE. Medical Press Srl; 2009. Italian.
4. Girolamo G, Polidori G, Morosini P, et al. Prevalence of common mental disorders in Italy: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl. 2004;420:21–7.
5. Mathers C, Boerma T, Ma Fat D. The global burden of disease: 2004 update. World Health Organization 2008. http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf . Accessed May 21, 2013.